Clinical Trials
7 trialsNCT04862455 2026-01-23
NBTXR3, Radiation Therapy, and Pembrolizumab for the Treatment of Recurrent or Metastatic Head and Neck Squamous Cell Cancer
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT03509584 2023-06-15
Phase I Multicenter Trial Combining Nivolumab, Ipilimumab and Hypo-fractionated Radiotherapy for Pretreated Advanced Stage Non-small Cell Lung Cancer Patients
Assistance Publique Hopitaux De Marseille
Phase 1 Terminated
NCT04372927 2023-06-13
ADMIRAL Trial: Adaptive Mediastinal Radiation With Chemo-Immunotherapy
University of Washington
Phase 2 Terminated
NCT04535908 2022-10-03
Hypofractionated Radiotherapy in Prostate Cancer Patients Aged 75 Years or Older.
Medical University of Graz
Phase NA Terminated
NCT03050060 2022-06-22
Image Guided Hypofractionated Radiation Therapy, Nelfinavir Mesylate, Pembrolizumab, Nivolumab and Atezolizumab in Treating Patients With Advanced Melanoma, Lung, or Kidney Cancer
University of Washington
Phase 2 Terminated
NCT02201355 2021-02-02
Hypofractionated Reduced-Volume Chemoradiation for T1/2N0-2 SCC Head and Neck
University of Texas Southwestern Medical Center
Phase 1 Terminated
NCT02672033 2020-07-24
Accelerated Hypofractionated Radiation Therapy Immediately Before Surgery in Treating Patients With Malignant Pleural Mesothelioma
Jonsson Comprehensive Cancer Center
Phase NA Terminated